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ABSTRACT
A sample of caecal effluent was obtained from a female patient who had undergone
a routine colonoscopic examination. Bacteria were isolated anaerobically from the
sample, and screened against the remaining filtered caecal effluent in an attempt
to isolate bacteriophages (phages). A lytic phage, named KLPN1, was isolated
on a strain identified as Klebsiella pneumoniae subsp. pneumoniae (capsular type
K2, rmpA+). This Siphoviridae phage presents a rosette-like tail tip and exhibits
depolymerase activity, as demonstrated by the formation of plaque-surrounding
haloes that increased in size over the course of incubation. When screened against
a panel of clinical isolates of K. pneumoniae subsp. pneumoniae, phage KLPN1
was shown to infect and lyse capsular type K2 strains, though it did not exhibit
depolymerase activity on such hosts. The genome of KLPN1 was determined to
be 49,037 bp (50.53 %GC) in length, encompassing 73 predicted ORFs, of which
23 represented genes associated with structure, host recognition, packaging,
DNA replication and cell lysis. On the basis of sequence analyses, phages KLPN1
(GenBank: KR262148) and 1513 (a member of the family Siphoviridae, GenBank:
KP658157) were found to be two new members of the genus “Kp36likevirus.”
Subjects Biodiversity, Ecology, Genomics, Microbiology, Virology
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INTRODUCTION
Metagenomic studies on samples from a range of different environments and the potential
of bacteriophage (phage) therapy to treat antibiotic-resistant, clinically relevant bacteria
have renewed interest in virus-like particles (VLPs). Metagenomic (virome) studies, in
particular, have demonstrated that VLPs are the most genetically diverse entities in the
biosphere (Reyes et al., 2012). Given their staggering abundance and diversity, coupled to
their perceived crucial role in the functioning of ecosystems, it is surprising that VLPs
(and by extension, phages) remain the most poorly characterized biological entities
(Reyes et al., 2012).
Virome and classical studies examining VLPs in the faeces of adults and infants have
demonstrated that there is a vast diversity and abundance of phages associated with the
human gut microbiota (Breitbart et al., 2003; Breitbart et al., 2008; Lepage et al., 2008;
Reyes et al., 2010; Kim et al., 2011; Minot et al., 2011; Wagner et al., 2013; Hoyles et al.,
2014). Similar to the prokaryotic make-up of the human gut microbiota, each individual
harbours a unique virome (dsDNA, ssDNA, RNA) that is temporally stable, and whose
composition appears to be influenced by diet (Reyes et al., 2010; Minot et al., 2011; Minot
et al., 2013). Lepage et al. (2008) reported that mucosal biopsies taken from healthy
individuals and Crohn’s patients contained between 4.4× 107 and 1.7× 1010 (mean
1.2× 109) VLPs/biopsy, with Crohn’s patients harbouring significantly more VLPs in their
biopsies than healthy individuals. A recent study in which phage populations in human
faecal and caecal-effluent samples were estimated using epifluorescence microscopy (EFM)
and transmission electron microscopy (TEM) reported the presence of up to 1012 VLPs/g
faeces (EFM) and at least 1× 105 VLPs/ml caecal effluent (TEM) (Hoyles et al., 2014).
However, little is known about the host ranges of these VLPs, and their abundance within
other regions of the gastrointestinal tract.
Generation of comprehensive gut virome data has been hampered by the lack of
available methods for concentrating VLPs within faecal samples and extracting sufficient
amounts of DNA from them so sequencing can be performed without the need to amplify
the template DNA (Reyes et al., 2012). However, the recent publication of a PEGylation
method applied to human faecal samples and demonstration that microgram quantities
of DNA can be isolated from faecal VLPs has gone some way to overcome this substantial
technical hurdle (Hoyles et al., 2014). When it comes to annotation of virome sequence
data, a major stumbling block is the lack of available phage genome sequences against
which contigs can be compared, plus the large number of viral genes that are currently
not represented in sequence databases. For example, studies of the human faecal virome
have reported that between 66% and 98% of the generated sequences have no significant
hits with GenBank sequences (Breitbart et al., 2008; Reyes et al., 2010; Minot et al., 2011).
There are few, if any, available sequences for human-gut-associated lytic phages so there is
a need to isolate and genomically characterize phages from gastrointestinal sources, rather
than relying on the assumption that phages found in sewage are primarily of human
gut origin. However, sequences of (predicted) prophages from genome sequences of
bifidobacteria, lactobacilli, Helicobacter pylori and Escherichia coli (strain Nissle 1917)
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of gastrointestinal origin are available (Ventura et al., 2005; Villion & Moineau, 2009;
Vejborg et al., 2010; Luo et al., 2012).
During a study of the microbiota associated with the caecum of patients with Irritable
Bowel Syndrome and healthy controls, attempts were made to isolate bacterium–phage
combinations from samples of caecal effluent. Herein, we report the isolation and
characterization of a Klebsiella pneumoniae subsp. pneumoniae–phage combination from
the caecal effluent of a healthy woman, and the implications of our findings in relation
to gastrointestinal microbial ecology and the potential of the human gut as a source of
phages with therapeutic uses. Previous studies describing the isolation of lytic phages
against K. pneumoniae have reported recovery of these entities from wastewater, seawater,
sewage and sewage-contaminated water samples, but never directly from gastrointestinal
contents (Souza, Ginoza & Haight, 1972; Kumari, Harjai & Chhibber, 2009; Kumari, Harjai
& Chhibber, 2010a; Drulis-Kawa et al., 2011; Hung et al., 2011; Cui et al., 2012; Hsu et al.,
2013; Karumidze et al., 2013; Jamal et al., 2015).
MATERIALS AND METHODS
Ethical approval and patient information
Ethical approval to collect caecal effluent from patients was obtained from St Thomas’
Hospital Research Ethics Committee (06/Q0702/74) covering Guy’s and St Thomas’
Hospitals, and transferred by agreement to London Bridge Hospital. Patients provided
written consent to provide samples. The caecal effluent was collected as described by Hoyles
et al. (2014) from a 31-year-old female who showed no evidence of colonic abnormalities
or disease as based on a routine colonoscopic examination.
Sample processing, and isolation of bacteria and phages from
caecal effluent
The sample was transported to the University of Reading under anaerobic conditions (in
a gas jar with an anaerobic gas-generating pack; Oxoid Ltd, Hampshire, UK) and on ice,
where it was processed within 3 h of collection. The sample was transferred to an anaerobic
cabinet (Whitley MG1000 anaerobic workstation; DW Scientific, West Yorkshire, UK;
gas composition 80% N2, 10% H2, 10% CO2) and mixed well by shaking. An aliquot
(1 ml) of the sample was diluted with 9 ml sterile, anaerobic half-strength peptone water
(Oxoid) in a sterile universal bottle containing 2-mm glass beads. A dilution series (10−1
to 10−6) was prepared from the homogenate in sterile, anaerobic half-strength peptone
water (Oxoid). Aliquots (20 µl) were plated in triplicate onto fastidious anaerobic agar
(BIOTEC laboratories, Ipswich, UK) containing 5% laked horse blood. Bacteria were
incubated anaerobically for 5 days at 37 ◦C, and then enumerated. Ten colonies were
selected randomly, streaked to purity, and stored on Microbank cryogenic beads (Prolab
Diagnostics, Merseyside, UK) at−70 ◦C.
The remaining neat caecal effluent (∼25 ml) was processed as described by Hoyles
et al. (2014). Briefly, the sample was diluted 1:4 (v/v) with sterile TBT buffer (100 mM
Tris/HCl, pH 8.0; 100 mM NaCl; 10 mM MgCl2 · 6H2O filtered through a 0.1 mm pore
size filter prior to autoclaving). The sample was homogenized in a stomacher (Stomacher
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400 Lab System; Seward, West Sussex, UK) for 2 min at ‘high’ speed, and then placed on
ice for 2 h to allow detachment of phages from and settlement of particulate material. The
homogenate was centrifuged at 11,180 g for 30 min at 4 ◦C, and the supernatant passed
through a sterile 0.45 µm cellulose acetate filter (Millipore, Billerica, Massachusetts, USA).
The filtrate was stored at 4 ◦C until used in spot assays.
Identification of isolated bacteria
DNA was isolated from bacteria using InstaGene Matrix (Bio-Rad, Deeside, UK) according
to the manufacturer’s instructions. Partial (∼600 nt) 16S rRNA gene sequences were
obtained for the isolates via the University of Reading’s Biocentre. Nearest relatives
of isolates were determined using EzTaxon (Chun et al., 2007). The identity of strain
L4-FAA5, tentatively identified as Klebsiella pneumoniae on the basis of its 16S rRNA gene
sequence, was confirmed using a species-specific PCR that detects the 16S–23S internal
transcribed spacer unit of K. pneumoniae as well as capsular-type-specific, and virulence
gene targets (Turton et al., 2010). Malonate and Voges–Proskauer reactions were positive
indicating that the isolate was subsp. pneumoniae (rather than subsp. ozaenae) (Turton et
al., 2010). Typing was carried out by VNTR analysis at loci A, E, H, J, K and D (Turton et
al., 2010) and an additional three loci (N1, N2 and N4). Primers, repeat sizes and flanking
sequence sizes for the additional loci were: N1F 5’-CATCAGGTGCAAGATTCCA-3’ and
N1R 5’- TGAGCGATTGCTGGCCTA-3’, 116 bp repeat with a 107 bp flanking sequence;
N2F 5’-GATGCGGCAAGCACCAC-3’ and N2R 5’-ACGCCCTGACCATTATGC-3’, 57 bp
repeat with a 109 bp flanking sequence; and N4F 5’-GTGCGGTGATTGTGATGG-3’ and
N4R 5’-CTGACAACGTCGATGTGG-3’, 67 bp repeat with a 119 bp flanking sequence.
Screening of bacteria against filtered caecal effluent
K. pneumoniae strains isolated from the caecum were grown to OD660 ∼ 0.4 in tryptone
soya broth (Oxoid Ltd), and used in spot assays as follows. An aliquot of culture (200 µl)
was inoculated into 3 ml tryptone soya broth containing 0.3% (w/v) agarose (SeaKem
LE agarose; Lonza Rockland) that had been heat-treated by microwaving and dispensed
aseptically from a larger volume before cooling to 48 ◦C. The overlays containing bacteria
were poured over 20 ml solid agar plates of autoclaved tryptone soya agar (Oxoid Ltd).
Once the agar had solidified, a 10 µl spot of filtered caecal effluent was applied to the
overlays, and the plates were incubated overnight at 37 ◦C in the anaerobic cabinet.
Identical plaques were observed on all K. pneumoniae isolates; strain L4-FAA5 was used
to propagate and purify an isolated phage in tryptone soya broth or reinforced clostridial
and nutrient media (Oxoid Ltd). Neither calcium nor magnesium was added to media
during propagations.
The ability of the purified phage to infect a panel of K. pneumoniae subsp. pneumoniae
clinical isolates (Table 1) was determined using the spot assay as described above, except
that nutrient agar plates were used for the base. Strain L4-FAA5 was used as a positive
control.
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Table 1 Description of K. pneumoniae subsp. pneumoniae isolates against which phage KLPN1 was screened.
Straina Capsular type
(K PCR result)b
rmpA wcaG Source Infected by
phage KLPN1
L4-FAA5 K2 + – Human caecal effluent Yes
K/5216 K1 (K1 cluster of CC23) + + Liver abscess (Taiwan) No
NCTC 5055 K2 (reference strain) + – Human Yesd
NCTC 9660 K5 (reference strain) – – Cloacae of horse No
PHE1 – – – Rectal swab No
PHE2 – – – Human clinical No
PHE3 – – – Sputum, transplant patient No
PHE4 – – – Urine, spinal injury patient No
PHE5 – – – Human blood No
PHE6 – – + Urine, incontinent patient No
PHE7 – – – Human clinical No
PHE8 – – – Human blood No
PHE9 – – – Human clinical No
PHE10 – – – Human blood No
PHE11c K2 – – Blood, patient with urinary tract infection Yesd
PHE12c K2 – – Urine Yesd
PHE13 K2 – – Blood and sputum, patient with bacteraemia and pneumonia Yesd
PHE14 K2 + – Sputum, patient with bacteraemia Yesd
PHE15 K2 – – Urine, cardiac patient Yesd
PHE16 K20 + – Sputum, transplant patient No
PHE17 K54 – + Intensive care unit No
PHE18 K57 – – Sputum, transplant patient No
Notes.
nd, No data.
a Strains with the prefix PHE were submitted for typing by healthcare providers to Public Health England–Colindale. Each isolate represented a distinct strain, with the
exception of isolates PHE11 and PHE12.
b K PCR can detect K1, K2, K5, K20, K54 and K57 capsular types.
c Corresponds to multi-locus sequence type ST14, often seen among multi-drug-resistant isolates producing carbapenemases.
d Phage KLPN1 did not exhibit depolymerase activity on these K2 isolates, but it did on L4-FAA5.
Purification of phage particles
A 100-ml culture of strain L4-FAA5 was grown to mid-exponential phase, inoculated with
100 µl of phage stock (∼1010 pfu/ml) and incubated until the medium became clear (∼2 h
after infection). The lysate was centrifuged at 4,500 g for 10 min, then passed through a
0.45 µm cellulose acetate filter. PEG 8000 (10%, w/v) and NaCl (6%, w/v) were added to
the filtrate, and mixed until all particulates had dissolved. The sample was left at 4 ◦C for
16 h, then centrifuged at 4,500 g for 30 min. The supernatant was removed and the pellet
resuspended in 4 ml TBT buffer. A CsCl block gradient was formed with 5 M and 3 M
CsCl, both prepared in TBT buffer and samples were placed on top of this gradient and
subjected to centrifugation at 100,000 g for 2 h at 4 ◦C. The band containing∼2 ml of TBT
buffer and the phages was drawn out of the tube and the purified sample was transferred to
dialysis tubing (4,000–6,000 Da cut-off), and dialysed against TBT buffer overnight. The
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TBT buffer was replaced with fresh TBT buffer, and the sample dialysed for a further 4 h.
The purified phage particles were removed from the dialysis tubing and stored at 4 ◦C.
Transmission electron microscopy
This was done as described by Hoyles et al. (2014).
Extraction of DNA from phage KLPN1 and restriction enzyme
profiles
An aliquot (250 µl) of the purified phage particle stock was treated with DNAse (2 U) for
30 min at 37 ◦C, then heated for 10 min at 80 ◦C. Two phenol/chloroform extractions were
performed, before the DNA was precipitated using 1/10 volume of 3 M sodium acetate (pH
4.8) and 2 volumes of ice-cold ethanol. After air-drying, DNA was resuspended in 100 µl
TE buffer. Restriction profiles were obtained for phage KLPN1 using the enzymes EcoRV
and HaeIII (SuRE/Cut; Roche Applied Science, Basel, Switzerland): restriction digests
contained 3 µl H2O, 1 µl enzyme, 1 µl enzyme buffer and 5 µl DNA, and were incubated
for 3 h at 37 ◦C before being run on a 0.8% (w/v) agarose gel (1 h, 75 V) and stained with
ethidium bromide.
Whole-genome sequencing and annotation of the phage genome
DNA (5 µg) was extracted and concentration verified by Nanodrop quantification.
Confirmatory molecular identification tests were also conducted on the DNA extract
prior to shipment to the contract sequencing facility (Macrogen Inc., Seoul, Korea).
Eighty-fold sequencing coverage was obtained using pyrosequencing technology on a 454
FLX instrument. The individual sequence files generated by the 454 FLX instrument were
assembled with GSassembler (454 Lifesciences, Branford, Connecticut, USA) to generate a
consensus sequence. To ensure correct assembly and resolve any remaining base-conflicts,
short segments of the genome were amplified by PCR and the generated amplicons were
then subjected to Sanger sequencing (MWG, Ebersberg, Germany). Open reading frames
(ORFs) were automatically predicted using Genemark (Besemer & Borodovsky, 1999). Gen-
eral feature format (gff) files were generated for the predicted phage proteome (retaining
proteins with a minimum size of 30 amino acids) and visualized using the annotation
software Artemis v10.0 (Rutherford et al., 2000). ORF boundaries were verified and,
where required, adjusted by manual inspection of Shine–Delgarno sequences. BLASTP
(Altschul et al., 1990) was used to provide preliminary functional annotation data, and to
carry out a comparative analysis of KLPN1 with previously sequenced Klebsiella phages
at the protein level (Altschul et al., 1990). To improve genome annotations/predictions,
all proteins encoded by ORFs in the genome sequence of KLPN1 were searched against
InterProScan (http://www.ebi.ac.uk/interpro/). HHpred (http://toolkit.tuebingen.mpg.
de/hhpred) searches were done to identify domains associated with depolymerase activity.
Screening virome datasets for phage sequences related to KLPN1
Fasta files associated with public virome datasets were downloaded from the METAVIR
web server (http://metavir-meb.univ-bpclermont.fr; Roux et al., 2011) on 31 March 2015
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(Table S1). Each fasta file was used to create a BLAST database, against which the genome
sequence of phage KLPN1 was searched using BLASTN.
RESULTS
Isolation and characterization of bacteria isolated from caecal
effluent
On fastidious anaerobe agar, 2.22× 108 ± 5.30× 107 (n = 3 replica plating) bacteria
were isolated per millilitre of caecal effluent sample (log10 8.35± 7.72 bacteria/ml caecal
effluent). Ten colonies were randomly selected from one of the triplicate plates used to
enumerate the bacteria, and streaked to purity. On the basis of 16S rRNA gene sequence
analysis (EzTaxon), isolates represented Klebsiella pneumoniae (n= 5), Bacteroides vulgatus
(n= 2), Bacteroides massiliensis (n= 1), a novel member of the order Erysipelotrichales dis-
tantly related to [Clostridium] innocuum (n = 1), and Haemophilus parainfluenzae (n = 1).
It is widely accepted that identification of members of the family Enterobacteriaceae
is difficult on the basis of 16S rRNA gene sequence data alone; therefore, one of the
strains identified as K. pneumoniae, L4-FAA5, was characterized using the PCR-based
methods of Turton et al. (2010). The isolate was found to be a strain of K. pneumoniae
subsp. pneumoniae, capsular type K2, rmpA+. Its VNTR profile was unique among the
clinical isolates tested and on the wider database of clinical isolates held by Public Health
England–Colindale.
Screening of filter-sterilized caecal effluent against bacteria to
isolate phages
The K. pneumoniae isolates were used in spot assays with the caecum filtrate, which was
free of bacteria (as verified by Gram-stained smear and plating on nutrient agar; not
shown). Phages infecting these isolates were initially identified in the caecal effluent by
spotting 10 µl aliquots of filtered caecal effluent onto TSA overlays containing 200 µl of
a given culture in the exponential phase of growth. Plaques identical to those shown in
Fig. 1A were observed with all K. pneumoniae isolates in the spot assays, and phages were
present at 2× 105 ± 2.65× 103 (n = 3) pfu/ml caecal effluent. Clear plaques of 2 mm di-
ameter were visible within 3 h of spotting onto an agar overlay. After prolonged incubation,
the area around the plaques developed opaque haloes presumably caused by depolymerase
activity, which increased in size over the course of 4 days, although the central clear area of
the plaques remained 2 mm in diameter (Fig. 1B). This phenomenon has been observed
previously for lytic phages of the families Siphoviridae, Podoviridae and Myoviridae against
K. pneumoniae, and is associated with degradation of capsular polysaccharides (Geyer et
al., 1983; Verma, Harjai & Chhibber, 2009; Hsu et al., 2013; Lin et al., 2014a; Shang et al.,
2015). The non-Klebsiella isolates were not screened against the caecum filtrate for phages.
Strain L4-FAA5 was used as the host bacterium on which to isolate and propagate one
phage (which we named KLPN1) to purity. KLPN1 infected all K. pneumoniae isolates
recovered from the filter-sterilized caecal effluent.
The ability of phage KLPN1 to infect a panel of K. pneumoniae subsp. pneumoniae
clinical isolates was determined (Table 1), which revealed that all K2 strains tested
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Figure 1 Appearance of plaques formed on K. pneumoniae subsp. pneumoniae L4-FAA5 by phage
KLPN1. (A) Initial isolation of phages from filtered caecal effluent on TSA. (B) Appearance of plaques of
pure phage stock after 24 h. (C) Growth of haloes surrounding plaques over the course of the course of
96 h. After 48 h, presumed phage-insensitive mutants can be seen growing in the haloes surrounding the
plaques. Images are shown to scale.
(including the type strain) were sensitive to this phage, though KLPN1 did not infect
any of the other tested strains belonging to other capsular types. VNTR analysis showed
that the six K2 isolates in the panel represented five, distinct strains, suggesting a wide
susceptibility to the phage among isolates of this capsular type. In addition, it did not
exhibit depolymerase activity with any of the clinical K2 isolates.
Characterization of phage KLPN1
Phage KLPN1 is chloroform-resistant. In addition, it displayed stability to prolonged
storage in TSB at 4 ◦C: after 6 and 18 months’ storage, titres for the phage were still 1010
pfu/ml, comparable with the original stock. Transmission electron microscopy revealed
the isometric-headed phage to possess a capsid of ∼62.7 ± 2.3 nm (n = 30) in diameter
with a long non-contractile tail of ∼164.4 ± 3.0 nm (n = 29), thus indicating that this
phage is a member of the family Siphoviridae (Fig. 2). Notably, the base-plate structure was
unusual with a distinct central tail fibre [length 33.4± 1.7 nm (n = 43)] with apparently
three elongated spherical structures [length, 13.2± 1.3 nm (n = 43); width, 6.9± 0.7 nm
(n = 48)] loosely associated with the central regions of the tail fibre. This unique base-plate
structures resembles a rosette with three leaves, and can be observed in all five micrographs
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Figure 2 Transmission electron micrographs of phage KLPN1. The phage belongs to the family
Siphoviridae, and has an unusual base-plate structure, resembling a rosette. The arrows indicate the
central tail fibre surrounded by three flexible spherical base-plate structures.
shown in Fig. 2. A similar structure has been described for Rtp, a lytic phage of Escherichia
coli (Wietzorrek et al., 2006), with which KLPN1 shares some sequence identity (discussed
below). It is also visible in electron micrographs of phage φ28, which infects K. pneumoniae
capsular type K28 (Geyer et al., 1983).
It was straightforward to isolate high-quality DNA from phage KLPN1. Heating an
aliquot of CsCl-purified, DNAse-/RNAse-treated sample at 80 ◦C for 10 min followed
by phenol/chloroform/isoamyl alcohol extractions and ethanol precipitation gave large
quantities of high-quality DNA that was used for restriction digests (not shown) and
genome sequencing. The estimated genome size of KLPN1 based on restriction digests
with EcoRV or HaeIII was∼45 kbp, which was an underestimation of the genome size of
49,037 bp as determined by sequencing (see below).
Sequence analysis of KLPN1
The genome of KLPN1 was 49,037 bp with a G + C content of 50.53%, similar to
previously sequenced Klebsiella Siphoviridae phages such as KP36 (Table 2). Initial genome
annotation was performed using Genemark (Besemer & Borodovsky, 1999), from which
a gff file was generated to allow visualisation of the predicted ORFs in Artemis v10.0
(Rutherford et al., 2000). Each ORF with a minimum amino acid content of 30, a start
and stop codon as well as a ribosomal-binding site was retained (Table 3). The genome of
KLPN1 was predicted to encompass 73 ORFs divided into four clusters, two rightward and
two leftward (Fig. 3, Table 3). Of the 73 predicted ORFs, 23 were assigned a function with
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Table 2 Characteristics of previously sequenced Klebsiella phages.
Phage Family Size (bp) G+C(%) No. of predicted ORFs GenBank accession no. Reference
NTUH-K2044-K1-1 Podoviridae 43,871 54.2 35 NC 025418 Lin et al. (2014a)
F19 Podoviridae 43,766 53.8 51 NC 023567 –
K11 Podoviridae 41,181 53.2 51 NC 011043 –
KP34 Podoviridae 43,809 54.1 57 NC 013649 Drulis-Kawa et al. (2011)
KP32 Podoviridae 41,119 52.4 44 NC 013647 Ke˛sik-Szeloch et al. (2013)
P13 Podoviridae 45,976 51.7 50 – Shang et al. (2015)
0507-KN2-1 Myoviridae 159,991 46.7 154 NC 022343 Hsu et al. (2013)
JD001 Myoviridae 48,814 48.5 68 NC 020204 Cui et al. (2012)
KP27 Myoviridae 174,413 41.8 276 NC 020080 Ke˛sik-Szeloch et al. (2013)
KP15 Myoviridae 174,436 41.8 258 NC 014036 Ke˛sik-Szeloch et al. (2013)
vB KleM-RaK2 Myoviridae 345,809 32 534 NC 019526 Sˇimoliu¯nas et al. (2012)
K64-1 Myoviridae 346,602 31.72 64 AB897757 Pan et al. (2015)
KP36 Siphoviridae 49,820 50.7 80 NC 019781 Ke˛sik-Szeloch et al. (2013)
phiKO2 Siphoviridae 51,601 51.5 64 NC 005857 Casjens et al. (2004)
1513 Siphoviridae 49,462 50.61 72 KP658157 Cao et al. (2015)
KLPN1 Siphoviridae 49,037 50.5 73 KR262148 This study
Figure 3 Genome structures of the four members of the genus “Kp36likevirus”. Phages KLPN1, KP36
and 1513 are virulent to K. pneumoniae, while F20 is virulent to Enterobacter aerogenes (Mishra, Choi &
Kang, 2012).
the remainder representing hypothetical proteins with no assignable function (Table 3).
BLAST analysis of the complete nucleotide sequence indicated that KLPN1 is closely
related to the Klebsiella phages KP36 (95% identity across 86% of the genome; Ke˛sik-
Szeloch et al., 2013), F20 (84% identity across 82% of the genome, GenBank accession no.
JN672684; Mishra, Choi & Kang, 2012) and phage 1513 (95% identity across 85% of the
genome, GenBank accession no. KP658157; Cao et al., 2015). Furthermore, partial identity
was observed against Shigella phage Shfl1 as well as enterobacterial phages T1 (Roberts,
Hoyles et al. (2015), PeerJ, DOI 10.7717/peerj.1061 10/25
Table 3 Genomic structure of phage KLPN1.
KLPN1 genome Start Stop Ribosome-binding
site
Start Strand Predicted product* Representative ORF in phage (% amino acid identity)
KP36 F20 1513 phiKO2
KLPN1 01 516 1079 AAGGAG ATG + Unknown – – – –
KLPN1 02 1069 1290 AGGAGG ATG + HP – – – –
KLPN1 03 1395 1547 GAGGAA ATG + HP pSf1 0028 (Shigella phage pSf-1) – – 39 (94) –
KLPN1 04 1752 1997 GAAGAtAG TTG + HP (Escherichia phage e4/1c) – – 38 (98.36) –
KLPN1 05 2186 2416 AGGAGGA ATG + HP KP36 04 KP36 04 (74.65) 76 (63.38) 37 (92.11) –
KLPN1 06 2487 2699 AGAGGA ATG + HP KP36 06 KP36 06 (82.86) – 36 (90) –
KLPN1 07 2710 3030 AAGGAGAA ATG + HP KP36 11 KP36 11 (78.3) 70 (65.09) 35 (82.08) –
KLPN1 08 3100 3471 GGAGA ATG + HP (Enterobacteria phage F20) – 69 (83.74) – –
KLPN1 09 3481 3783 GAGGtGGccG ATG + HP KP36 15 KP36 15 (91) 68 (56) 33 (85) –
KLPN1 10 3783 4028 AAcGGGA ATG + HP KP36 16 KP36 16 (97.53) 67 (83.95) 32 (92.59) –
KLPN1 11 4025 4210 GAGGtAAAAG ATG + HP KP36 17 KP36 (signal peptide) 17 (85.25) 66 (78.69) 31 (58.18) –
KLPN1 12 4291 4500 AAtcAGGAG ATG + HP (Enterobacteria phage F20) – 65 (73.91) – –
KLPN1 13 4500 4934 GAGGAGA ATG + HP (Enterobacteria phage F20) 19 (33.93) 64 (32.54) 29 (35.58) –
KLPN1 14 5004 5750 AAGAGGAA ATG + HP (Enterobacteria phage F20) 20 (50.94) 63 (54.55) 28 (34.84) –
KLPN1 15 5827 6099 AGGAG ATG + HP KP36 22 KP36 22 (65.56) 61 (66.67) – –
KLPN1 16 6096 6668 AAGGtGAtcGAA ATG + HP KP36 23 KP36 23 (96.32) 60 (78.53) 25 (76.44) –
KLPN1 17 6738 6974 AAGGAG ATG + HP KP36 24 KP36 24 (92.31) 59a (86.3) 24 (96.15) –
KLPN1 18 6962 7195 GGAGAAGG ATG + HP KP36 25 KP36 25 (100) 59 (87.01) 23 (95.45) –
KLPN1 19 7324 7518 AAAGGG ATG + HP KP36 26 KP36 26 (96.67) 57 (93.65) 22 (96.88) –
KLPN1 20 7512 7718 AAGGGAA ATG + HP KP36 27 KP36 (signal peptide) 27 (96.2) 56 (64.81) 21 (100) –
KLPN1 21 7773 8378 GAAGcGGcGtAA ATG + terminase small subunit KP36 28(92.53) 55 (91.95) 20 (90.8) –
KLPN1 22 8388 9992 AAGGGccGA ATG + terminase large subunit KP36 (terminase-like family: PF03237) 29 (99.25) 54 (98.13) 19 (99.44) –
KLPN1 23 10038 11348 AAAcAAGGttGA ATG + portal protein KP36 (phage portal protein, SPP1 Gp6-like: PF05133) 30 (98.62) 53 (91.78) 18 (99.31) –
KLPN1 24 11335 12102 GGAGGcGGA ATG + capsid morphogenesis protein KP36
(phage head morphogenesis domain: IPR006528)
31 (96.44) 52 (90.12) 17 (95.22) –
KLPN1 25 12104 12589 GAGGttAG ATG + HP gp40 (Escherichia phage phiEB49) HNH endonuclease
(HNH endonuclease: PF13392)
– – – –
KLPN1 26 12586 13716 GGAGA ATG + capsid protein KP36 32 (99.47) 51 (93.09) 16 (99.47) –
KLPN1 27 13768 14286 AGGAGA ATG + HP KP36 33 KP36 33 (96.2) 50 (50.87) 15 (96.84) –
KLPN1 28 14400 15359 AGGAG ATG + major capsid protein KP36 34 KP36 34 (98.75) 49 (94.36) 14 (98.43) –
KLPN1 29 15451 15756 GGAGcA ATG + HP KP36 35 KP36 35 (100) 48 (86.15) 13 (98.77) –
KLPN1 30 15753 16226 AAAAGcGcGGA ATG + HP KP36 36 KP36 36 (100) 47 (92.75) 12 (97.83) –
KLPN1 31 16232 16609 GGtAGGtGA ATG + HP KP36 37 KP36 37 (99.2) 46 (94.4) 11 (98.4) –
KLPN1 32 16602 17039 AGGGtGGcGA ATG + HP KP36 38 KP36 38 (100) 45 (92.41) 10 (99.05) –
(continued on next page)
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Table 3 (continued)
KLPN1 genome Start Stop Ribosome-binding
site
Start Strand Predicted product* Representative ORF in phage (% amino acid identity)
KP36 F20 1513 phiKO2
KLPN1 33 17029 17463 GAGcGAGG ATG + HP (Enterobacteria phage F20) Tail protein (phage tail protein: PF13554) 39 (76.39) 44 (88.19) 09 (74.19) –
KLPN1 34 17450 18136 GGAGGcGA ATG + HP (Enterobacteria phage F20) Tail protein (phage tail protein: PF08813) – 43/42
(68.26/42.04)
08 (43.36) –
KLPN1 35 18189 18845 AGGAG ATG + HP (Enterobacteria phage F20) Tail protein (phage tail protein: PF08813) 40 (91.67) 42 (82.87) 08 (96.33) –
KLPN1 36 18922 19248 AGGAG ATG + Tape measure chaperone protein
(domain of unknown function DUF1789: PF08748)
41 (98.15) 41 (57.01) 07 (98.15) –
KLPN1 36.1 19239 19562 – – + Tape measure chaperone protein
(phage-related hypothetical protein DUF1799: PF08809)
– 40 (92.73) 06 (96.36) –
KLPN1 38 19620 22565 GAtAAAGtAG TTG + tail length tape-measure protein KP36
(λ phage tail tape-measure protein: PF09718)
43 (91.63) 39 (80.22/68.85) 05 (91.04) –
KLPN1 39 22568 22912 AAcGAGGG GTG + minor tail protein KP36 (minor tail protein: PF05939) 44 (88.6) 38 (87.72) 04 (86.84) 16 (28.32)
KLPN1 40 22949 23734 – + minor tail protein KP36 (minor tail protein L: TIGR01600) 45 (93.17) 37 (91.27) 03 (92.77) 17 (36.78)
KLPN1 41 23736 24473 GAAAAGcGGAcGG ATG + minor tail protein KP36 (endopeptidase, NlpC/P60 family: PF00877) 46 (93.47) 36 (96.33) 02 (94.69) 18 (42.62)
KLPN1 42 24448 25050 AAGGA ATG + tail assembly protein KP36 (λ tail assembly protein I: PF06805) 47 (94.5) 35 (98) 01 (95.03) –
KLPN1 43 25138 28839 AGGAGG ATG + tail fiber protein KP36 (putative phage tail protein: PF13550) 48 (95.86) 34 (88.6) 01a (95.06) 21 (39.75)
KLPN1 44 29027 31297 AAGAGG ATG – HP L418 01651 (Klebsiellapneumoniae UCICRE 7)
(galactose-binding domain-like: IPR008979)
49 (66.79) 32 (83.49) 71 (70.15) –
KLPN1 45 31392 31853 AGGAAcGA ATG – single-stranded DNA binding protein KP36
(nucleic-acid binding proteins: SSF50249)
50 (98.04) 31 (82.35) 70 (96.08) –
KLPN1 46 31890 32546 AAGGAAA ATG – putative recombination protein KP36 (signal peptide) 51 (99.54) 30 (93.12) 69 (98.62) –
KLPN1 47 32606 33652 GGAGcAA ATG – exodeoxyribonuclease VIII KP36
(PD-(D/E)XK nuclease superfamily: PF12705)
52 (97.7) 29 (93.39) 68 (97.99) –
KLPN1 48 34148 35107 GGAGGtAA GTG – DNA primase KP36
(bacteriophage T7, Gp4, DNA primase/helicase, N-terminal: IPR013237)
53 (98.7) 28 (88.64) 67 (99.35) –
KLPN1 49 35183 35584 GAGGGttAA ATG – putative transcriptional regulator KP36
(λ repressor-like, DNA-binding domain: IPR010982)
54 (98.5) 27 (95.49) 66 (99.25) –
KLPN1 50 35676 37712 AGGAttG ATG + DNA helicase KP36 (helicase, C-terminal: IPR001650) 55 (98.52) 26 (94.25) 65 (98.82) –
KLPN1 51 37709 38116 GGAGGcGAGG GTG + HP KP36 56 KP36 (VRR-NUC domain: IPR014883) 56 (99.08) 25 (86.61) 64 (100) –
KLPN1 52 38181 38468 GAAGAAcGGA ATG + HP KP36 57 KP36 (signal peptide) 57 (95.65) – 63 (94.87) –
(continued on next page)
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Table 3 (continued)
KLPN1 genome Start Stop Ribosome-binding
site
Start Strand Predicted product* Representative ORF in phage (% amino acid identity)
KP36 F20 1513 phiKO2
KLPN1 53 38471 39202 GcGAGGttAA ATG + DNA adenine methyltransferase KP36
(phage N-6-adenine-methyltransferase: TIGR01712)
58 (97.53) 23 (92.59) 62 (97.94) –
KLPN1 54 39204 39440 GcGtAtGcGAA ATG + HP KP36 59 KP36 59 (88.46) 22 (79.49) 61 (89.74) –
KLPN1 55 39451 39741 – ATG + HP (Enterobacteria phage F20) 60 (98.72) 21 (83.33) 60 (98.72) –
KLPN1 56 39741 39989 GGtGAcGA ATG + HP KP36 61 KP36 61 (95.18) 20 (89.02) 59 (96.39) –
KLPN1 57 40085 41215 AAttGGGAtAA ATG + HP KP36 62 KP36 (metallo-dependent phosphatase-like: IPR029052) 62 (99.2) 19 (94.15) 58 (99.2) –
KLPN1 58 41254 41745 AAGGAAA ATG + 3’-phosphatase, 5’-polynucleotide kinase KP36
(HAD superfamily, subfamily IIIB (acid phosphatase): PF03767)
63 (93.87) 18 (75.46) 57 (95.09) –
KLPN1 59 41742 42323 GGAGtAGA ATG + HP KP36 64 KP36
(P-loop containing nucleoside triphosphate hydrolase: IPR027417)
64 (99.48) 17 (88.17) 56 (99.48) –
KLPN1 60 42450 42665 AGAGG ATG + holin KP36 65 (83.1) 16 (80.28) 55 (83.1) –
KLPN1 61 42667 43149 AGGAGcAAG ATG + endolysin KP36 (lysozyme-like domain: IPR023346) 66 (86.23) 15 (90.57) 54 (98.12) –
KLPN1 62 43146 43571 AAGGA ATG + Rz1A protein KP36 67 (96.45) 14 (89.36) 53 (99.29) –
KLPN1 63 43641 44102 GAGGtAA ATG – HP KP36 68 KP36 68 (98.69) 13 (88.89) 52 (98.69) –
KLPN1 64 44106 45674 AGGAGcAAGG ATG – HP KP36 69 KP36 (protein of unknown function DUF3987: PF13148) 69 (99.81) 12 (95.79) 51 (99.81) –
KLPN1 65 45800 46237 GGAGAAAG ATG – HP KP36 70 KP36 70 (97.93) 11 (91.03) 50 (98.62) –
KLPN1 66 46238 46420 GAAGAAA ATG – HP KP36 71 KP36 71 (93.33) 10 (86.44) 49 (93.33) –
KLPN1 67 46417 46620 GGAGtAAAcGGA ATG – HP KP36 72 KP36 72 (97.01) 09 (65.67) 48 (92.54) –
KLPN1 68 46693 47385 AAAtGGtGGA ATG – HP KP36 73 KP36 73 (97.83) 08 (90) 47 (96.96) 42 (56.83)
KLPN1 69 47382 47681 GGcAtAG TTG – HP KP36 74 KP36 74 (100) 06 (55.41) 46 (52.7) –
KLPN1 70 47688 48065 GAAAcGAGG ATG – HP KP36 75 KP36 75 (96) 05 (66.13) 45 (70) –
KLPN1 71 48065 48304 GAGAAGGG ATG – HP KP36 76 KP36 76 (96.2) 04 (93.1) 44 (97.47) –
KLPN1 72 48301 48495 AGGAGAA ATG – HP KP36 77 KP36 77 (93.75) 03 (84.81) 43 (95.31) –
KLPN1 73 48568 48849 AGAGGG ATG – HP KP36 78 KP36 78 (97.47) 02 (84.81) 42 (96.2) –
Notes.
* HP, hypothetical protein. Underlined predicted products are from InterProScan (http://www.ebi.ac.uk/interpro/) searches that returned results with the amino acid sequence encoded by each ORF (Table S2).
H
oyles
et
al.(2015),P
eerJ,D
O
I10.7717/p
eerj.1061
13/25
Martin & Kropinski, 2004) and RTP (Wietzorrek et al., 2006) (GenBank accession numbers
HM035024, AY216660 and AM156909, respectively). A comparative analysis of KLPN1
was performed against both known members (KP36, F20) of the genus “Kp36likevirus”
(Niu et al., 2014; Table 3, Fig. 3). For completion, KLPN1 was also compared with pre-
viously sequenced Klebsiella phages (Table 2). KLPN1 was shown not to share detectable
homology with Klebsiella phages belonging to the family Podoviridae or Myoviridae. Based
on the amino acid percentage identities presented in Table 3, the genomes of KLPN1 and
related phages were divided into functional conserved modules: packaging, phage particle
morphogenesis and DNA replication (Fig. 3, Table 3). Sections of the KLPN1 genome were
shown to exhibit homology to the Siphoviridae phage phiKO2 genome, although such
homology was confined to the tail morphogenesis region and one hypothetical protein
(Table 3). Of the 73 predicted ORFs, only three appeared unique to KLPN1: two genes
encoding hypothetical proteins located at the 5’ end of the genome and a putative homing
endonuclease-gene positioned in the capsid morphogenesis module (Table 3).
Based on sequence homology to ORF33 (encoding the host-specificity J protein;
InterPro IPR021034) of phage T1, the phage receptor-binding protein of KLPN1 was
predicted to be encoded by ORF43. The deduced ORF43 protein was found to exhibit
similarity to fibronectin type III domain-containing protein, and potentially encodes the
depolymerase whose effect was observed on the phage assay plates (Fig. 1). However,
a HHpred search with the protein sequence encoded by this ORF failed to detect any
domains associated with enzymes (such as glycanases, deacetylases and lyases) associated
with depolymerase activity of Klebsiella lytic phages (Geyer et al., 1983). The protein
encoded by ORF34 of phage NTUH-K2044-K1-1 has proven depolymerase activity
associated with pectate lyase (Lin et al., 2014a); a HHpred search confirmed the protein
encoded by this ORF has a lyase/polygalacturonase domain (1ru4 A pectate lyase,
94.3% probability of true positive, E-value 0.055, P-value 1.6× 10−6; 1bhe A PEHA,
polygalacturonase, 90.1% probability of true positive, E-value 13, P-value 0.00038).
ORF96 of phage 0507-KN2-1 also encodes proven depolymerase activity (Hsu et
al., 2013). A HHpred search demonstrated the protein encoded by this ORF has an
acetylneuraminidase domain (3gw6 A endo-N-acetylneuraminidase, 99.8% probability
of true positive, E-value 1× 10−19, P-value 2.9× 10−24). The whole-genome sequence of
phage P13 cannot be retrieved from GenBank; however, on the basis of a PSI-BLAST search
conducted by Shang et al. (2015), genes 49 and 50 of phage P13 are predicted to encode
the exopolysaccharide depolymerase, but no further substrate/functional information
is available. HHpred searches of all proteins encoded by KLPN1 showed that ORF34
and ORF35 encode an endo-N-acetylneuraminidase/endosialidase domain (Table 4).
Consequently, we predict ORF34 and/or ORF35 encode the depolymerase activity of phage
KLPN1. Further work will be required to confirm our hypothesis.
The proteins encoded by ORF36 and ORF36.1 are predicted to be two chaperones,
analogous to gpG and gpGT required for phage λ tail assembly (Xu, Hendrix & Duda,
2013). These ORFs are believed to keep the tail tape measure protein (TMP) soluble and
to recruit the major tail protein subunits, both essential processes for tail assembly. ORF36
Hoyles et al. (2015), PeerJ, DOI 10.7717/peerj.1061 14/25
Table 4 Selected HHpred results for ORF34 and ORF35 of phage KLPN1.
Hit Probability of
true positive
E-value P-value Score SS Cols ORF
amino
acids
Reference
ORF34
2k4q A Major tail protein V; GPV, bacteriophage lambda,
viral protein; NMR {Enterobacteria phage lambda}
99.9 1.3× 10−27 3.6× 10−32 195.4 7.6 124 99-224 Pell et al.
(2009)
3ju4 A Endo-N-acetylneuraminidase; endonf, polysia,
high-resolution, glycosidase, hydrolase; HET: SLB; 0.98A
{Enterobacteria phage K1F}
81.6 1.4 4.1× 10−5 42.0 4.1 93 23-123 Schulz et al.
(2010)
4hiz A Endosialidase, PHI92 GP143; sialidase fold,
beta-helix, endo-alpha2,8-sialidase, endo-Al sialidase sialic
acid polymer; HET: SLB SIA SUC; 1.60A
{Enterobacteria phage PHI92}
80.9 4 0.00012 39.1 6.8 65 23-95 Unpublished
ORF35
2k4q A Major tail protein V; GPV, bacteriophage lambda,
viral protein; NMR {Enterobacteria phage lambda}
99.9 5.3× 10−28 1.5× 10−32 195.1 8.6 119 94-214 Pell et al.
(2009)
4hiz A Endosialidase, PHI92 GP143; sialidase fold,
beta-helix, endo-alpha2,8-sialidase, endo-Al sialidase sialic
acid polymer; HET: SLB SIA SUC; 1.60A
{Enterobacteria phage PHI92}
91.4 0.55 1.6× 10−5 44.1 7.3 65 23-87 Unpublished
3ju4 A Endo-N-acetylneuraminidase; endonf, polysia,
high-resolution, glycosidase, hydrolase; HET: SLB;
0.98A {Enterobacteria phage K1F}
90.0 0.59 1.7× 10−5 43.8 6.2 65 23-87 Schulz et al.
(2010)
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Figure 4 ORF36 and ORF36.1 are related by a programmed-1 translational frameshift. The frameshift
allows translation of a gpGT-like protein (Xu, Hendrix & Duda, 2013). The ORF36/ORF36.1 fusion
protein is predicted to contain almost the entire sequence of ORF36. Citrobacter Siphoviridae phage Stevie
(GenBank accession number KM236241) has a conserved translational frameshift in its tape measure
chaperone (GenBank accession number AIX12284) (Shaw et al., 2015).
encodes the short chaperone (gpG), while a programmed -1 translational frameshift facil-
itates a translational fusion between the products of ORF36 and ORF36.1 so as to form the
long chaperone (gpGT) (hence the lack of a ribosome-binding site for ORF36.1) (Fig. 4).
A BLASTP search of the predicted 213 aa fusion protein showed it shares 47% identity
(E-value 3× 10−56) with the tape measure chaperone of the Citrobacter Siphoviridae phage
Stevie, reported to have a conserved translational frameshift (Shaw et al., 2015; Fig. 4).
The genome sequence of KLPN1 was subjected to BLASTN searches against all
publicly available virome sequence data held by METAVIR (51,992,208 sequence reads
associated with 70 projects from a range of habitats, including human faeces (Reyes
et al., 2010; Kim et al., 2011; Minot et al., 2011; Minot et al., 2013); Table S1). No hits
corresponding to KLPN1 were found among these publicly available datasets. However,
using InterProScan, the protein sequence encoded by ORF64 was found to belong
to the family ‘Protein of unknown function DUF3987’, representing uncharacterized
human-gut-microbiome-specific proteins (Ellrott et al., 2010; Table 3).
DISCUSSION
K. pneumoniae subsp. pneumoniae is an enteric bacterium and important nosocomial and
community-acquired opportunistic pathogen, causing pneumonia, and wound, burn,
urinary tract and blood infections. There are 79 recognized capsular types of K. pneumo-
niae subsp. pneumoniae, with capsular types K1, K2, K5, K54 and K57 most frequently
associated with invasive disease or pathogenicity; capsular type K20 is much rarer, though
there is regional variability in the predominant clinically relevant capsular types (Turton
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et al., 2010; Pan et al., 2013; Hsu et al., 2013). It has been suggested that the majority of
K. pneumoniae-associated liver infections are preceded by colonization of the gastroin-
testinal tract, and one study has demonstrated familial spread of a virulent clone of
K. pneumoniae causing liver disease (Harada et al., 2011; Lin et al., 2012). Using caecal
effluent recovered from a healthy woman, we have isolated a capsular type K2 rmpA+ strain
(L4-FAA5) of K. pneumoniae subsp. pneumoniae. After K1, K2 strains are most frequently
associated with pyogenic liver abscesses and frequently associated with community-
acquired pneumonia (Lin et al., 2014b). K1 and K2 strains, along with the rmpA (regulator
of mucoid phenotype A) gene, are associated with hypermucoviscosity and virulence.
A study examining K1 and K2 strains of K. pneumoniae in 43 Taiwanese patients with
liver abscesses showed, using pulsed-field gel electrophoresis (PFGE), that 17 randomly
selected pairs of patient faecal or saliva and abscess isolates allowed differentiation of
patients based on the PFGE profiles of their isolates. The abscess isolates had PFGE
profiles identical, or closely related to, those of faecal or saliva isolates from the same
patient (Fung et al., 2012). The similarity between each patient’s faecal and abscess PFGE
profiles led Fung et al. (2012) to suggest that the patients’ infections arose from bacteria
originating in the gut microbiota. Our isolation of a K. pneumoniae strain with virulence
traits from the human caecum supports the assertion that the human gut microbiota is a
source of potentially infectious K. pneumoniae. Limited data are available on the carriage
and diversity of gut/faecal K. pneumoniae. A study on healthy Chinese adults in Chinese
territories and overseas showed between 18.8 and 87.7% faecal carriage of K. pneumoniae,
with individuals in Malaysia (64/73) and Taiwan (150/200) showing the highest carriage
rates and those in Japan (6/32) showing the lowest (Lin et al., 2012). Isolates were tested
with antisera for capsular types K1–K74 and K80–82: K1 and K2 isolates accounted for
∼10% of isolates in all countries, at least one representative of each capsular type was
detected in the study and non-typable (11–88%) isolates were reported for 7/8 countries
(Lin et al., 2012). The high carriage of K. pneumoniae in Taiwan is thought to contribute to
the high incidence of liver abscess disease seen in the country (Fung et al., 2012).
As with other nosocomial opportunistic pathogens, broad-spectrum antibiotic
resistance is a feature of K. pneumoniae subsp. pneumoniae and limits treatment options
(Canto´n et al., 2012). Therefore, identification of alternative treatment therapies or
adjuncts to existing therapies for infections associated with this organism is of utmost
importance. Phages against K. pneumoniae subsp. pneumoniae have been used to success-
fully treat K. pneumoniae infections in animal models of sepsis, pneumonia, burn wounds
and liver disease, without causing apparent harm to animals (Bogovazova, Voroshilova &
Bondarenko, 1991; Malik & Chhibber, 2009; Chhibber, Kaur & Kumari, 2008; Kumari, Har-
jai & Chhibber, 2009; Kumari, Harjai & Chhibber, 2010b; Hung et al., 2011). The number of
known lytic phages that infect K. pneumoniae remains small and their range is limited to a
small number of capsular types (though phenotypic information on strains is absent from
the majority of publications on K. pneumoniae phages). Given the large number of phages
present in faeces and caecal effluent (Hoyles et al., 2014), and because K. pneumoniae subsp.
pneumoniae is a member of the human gut microbiota, we were keen to exploit this envi-
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ronment as a source of phages with potential therapeutic applications. We isolated from
caecal effluent a phage (named KLPN1) that infects K. pneumoniae subsp. pneumoniae L4-
FAA5 and K2 clinical isolates of K. pneumoniae subsp. pneumoniae (Table 1). Phage KLPN1
does not infect non-K2 clinical isolates (Table 1). To the best of our knowledge, this is the
first report of the isolation of a bacterium–phage combination from the human caecum.
To date, only eight phages infecting the K2 capsular type of K. pneumoniae have been
reported (Bogovazova, Voroshilova & Bondarenko, 1991; Malik & Chhibber, 2009; Kumari,
Harjai & Chhibber, 2010b; Hung et al., 2011). Several Podoviridae were isolated on K.
pneumoniae B5055 (assumed to be derived from NCTC 5055) and tested as therapeutic
agents [Kpn5, Kpn12, Kpn13, Kpn17, Kpn22 (individually and in cocktail) and KØ1] in
B5055-induced burn-wound infections in mice (Kumari, Harjai & Chhibber, 2009; Kumari,
Harjai & Chhibber, 2010a; Kumari, Harjai & Chhibber, 2010b; Malik & Chhibber, 2009).
Phage SS (Podoviridae) was isolated on B5055 and used to treat lobar pneumonia caused by
the same strain in mice (Chhibber, Kaur & Kumari, 2008). Phage φNK5 (Podoviridae) was
isolated from sewage on K. pneumoniae NK-5, isolated from a patient with a primary liver
abscess and septicaemia (Hung et al., 2011). The same bacterial strain was used to induce
liver abscesses and bacteraemia in mice, which were successfully treated with φNK5. None
of the aforementioned phages has been tested against a range of clinical K. pneumoniae
isolates. Therefore, it is difficult to assess how useful they would be in treatment of a wide
range of clinical infections, especially when similar infections can be caused by different
capsular types of K. pneumoniae (e.g., Table 1). We can state that KLPN1 has potential for
treating K2-associated infections, but note that differences in lytic infection were observed
between the caecal isolate and the clinical isolates: KLPN1 infected the caecal isolate and
exhibited depolymerase activity that was absent with the clinical K2 isolates. Further
investigations may reveal that its infection kinetics differ between K2 strains.
Hung et al. (2011) demonstrated the generation of phage-insensitive mutants after 6 and
12 h co-cultures of NK-5/φ NK5, with these mutants lacking the hypermucoviscosity
phenotype of NK-5. On solid media, phage-insensitive mutants of K. pneumoniae
L4-FAA5 were routinely observed after 48 h incubation with phage KLPN1. Whether
mutants are generated more quickly in liquid culture remains to be determined, as does
the nature of the mutations that allow them to escape lytic infection with KLPN1. Does
solid media act as a spatial refuge (Mills et al., 2013) for sensitive bacteria, delaying the
appearance of insensitive mutants?
It is predicted that many members of the human gut microbiota are embedded in
biofilms, and phages may contribute to cell lysis in these ecological niches (Mills et al.,
2013). The microbiota of the human caecum resides in a highly mucoid biofilm (Randal
Bollinger et al., 2007). Phage KLPN1 exhibits depolymerase activity on K. pneumoniae
L4-FAA5, which may facilitate the movement of the phage within the caecal biofilm. It
has been demonstrated that phages can diffuse within biofilms, be immobilized, amplified
and released after a lytic cycle in these environments. They may also potentially interact
with their specific binding sites on bacteria, even in the absence of lytic activity (Mills
et al., 2013). Further work is needed to understand interactions between K. pneumoniae
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L4-FAA5 and phage KLPN1 in single- and multi-strain biofilm systems, and to determine
whether the “spatial refuge hypothesis” (Mills et al., 2013) holds for the caecal microbiota,
preventing the extinction of all sensitive bacteria within the biofilm.
Following whole-genome sequencing and annotation, KLPN1 was found to encompass
73 ORFs and, based on its sequence homology to Klebsiella phages KP36 and F20, it is
evident that KLPN1 is a member of the family Siphoviridae, subfamily Tunavirinae,
and would become the third member of the genus “Kp36likevirus” (Niu et al., 2014).
In addition, based on our sequence analyses phage 1513 (a Siphoviridae that infects a
multidrug-resistant K. pneumoniae strain isolated from a patient with pneumonia; Cao
et al., 2015) can also be added to this genus, bringing the total number of members
to four. This classification would be consistent with the morphological appearance of
KLPN1, which has a capsid of 64 nm as well as rosette-like or propeller tail tip, a finding
also observed for phages φ28, T1 and RTP (Geyer et al., 1983; Wietzorrek et al., 2006).
Unsurprisingly, KLPN1 shares no sequence homology with Klebsiella phages belonging to
the families Myoviridae or Podoviridae; however, some similarities to Siphoviridae phage
phiKO2 were observed, but these were confined to the tail morphogenesis region and a
hypothetical protein. ORF60 and ORF61 are predicted to encode holin (which destroys
the cytoplasmic membrane) and endolysin (which degrades peptidoglycan), respectively.
These gene products have antibacterial properties that can be used in phage-associated
therapies (Viertel, Ritter & Horz, 2014); therefore, further characterization of the proteins
encoded by these ORFs is required.
CONCLUSIONS
We isolated a K. pneumoniae subsp. pneumoniae–phage combination from the human
caecum, and have characterized its lytic properties against a panel of K. pneumoniae
subsp. pneumoniae clinical isolates. Phage KLPN1 infects capsular type K2 isolates, and
may have applications in treating a range of K2-associated infections. We have, therefore,
demonstrated the gut microbiota as a source of clinically relevant phages. Whole-genome
sequence analysis of KLPN1 revealed the phage to encode proteins that have potential
applications in phage-associated therapies. Characterization of these gene products, or
genetically modified variants, is required to determine their usefulness.
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